SUBCUTANEOUS BORTEZOMIB IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA

被引：0
作者：
Violeta, Martinez-Robles [1 ]
Belen, Ballina [1 ]
Seila, Cerda [1 ]
Filomeno, Rondon [1 ]
Natalia, De Las Heras [1 ]
Jose-Antonio, Rodriguez-Garcia [1 ]
Fernando, Escalante [1 ]
机构：
[1] Complejo Asistencial Univ Leon, Leon, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-003
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
    Philippe Moreau
    Ievgenii I. Karamanesht
    Natalia Domnikova
    Maryna Y. Kyselyova
    Kateryna V. Vilchevska
    Vadim A. Doronin
    Alexander Schmidt
    Cyrille Hulin
    Xavier Leleu
    Dixie-Lee Esseltine
    Karthik Venkatakrishnan
    Donna Skee
    Huaibao Feng
    Suzette Girgis
    Andrew Cakana
    Helgi van de Velde
    William Deraedt
    Thierry Facon
    Clinical Pharmacokinetics, 2012, 51 : 823 - 829
  • [42] The characteristics of patients with multiple myeloma surviving over 10 years
    Huang, Beihui
    Zhang, Hongning
    Liu, Junru
    Gu, Jingli
    Chen, Meilan
    Kuang, Lifen
    Li, Xiaozhe
    Li, Juan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
    Moreau, Philippe
    Karamanesht, Ievgenii I.
    Domnikova, Natalia
    Kyselyova, Maryna Y.
    Vilchevska, Kateryna V.
    Doronin, Vadim A.
    Schmidt, Alexander
    Hulin, Cyrille
    Leleu, Xavier
    Esseltine, Dixie-Lee
    Venkatakrishnan, Karthik
    Skee, Donna
    Feng, Huaibao
    Girgis, Suzette
    Cakana, Andrew
    van de Velde, Helgi
    Deraedt, William
    Facon, Thierry
    CLINICAL PHARMACOKINETICS, 2012, 51 (12) : 823 - 829
  • [44] Bortezomib-Melphalan-Prednisone (VMP) Versus MP As Initial Treatment for Patients Older Than 75 Years with Newly Diagnosed Multiple Myeloma
    Kim, Min Kyoung
    Kim, Kihyun
    Yoon, Dok Hyun
    Suh, Cheolwon
    Lee, Jae Hoon
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Hyo Jung
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Lee, Won Sik
    Mun, Yeung-Chul
    Do, Young Rok
    Kang, Hye Jin
    BLOOD, 2016, 128 (22)
  • [45] Bortezomib in multiple myeloma
    Meisler, AI
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) : 1287 - 1287
  • [46] Bortezomib in multiple myeloma
    Mateos, M. V.
    Miguel, J. F. San
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 701 - 715
  • [47] Bortezomib in multiple myeloma
    Cecchi, M
    Caccese, E
    Messori, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) : 1297 - 1297
  • [48] Bortezomib in multiple myeloma
    不详
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) : 2335 - 2335
  • [49] Bortezomib in multiple myeloma
    Terpos, Evangelos
    Roussou, Maria
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (05) : 639 - 654
  • [50] Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age
    Larocca, Alessandra
    Cavallo, Federica
    Magarotto, Valeria
    Offidani, Massimo
    Federico, Vincenzo
    Innao, Vanessa
    Falcone, Antonietta Pia
    Romano, Alessandra
    Caravita, Tommaso
    Rossi, Davide
    Mansueto, Giovanna
    Mina, Roberto
    Nozzoli, Chiara
    Benevolo, Giulia
    Guglielmelli, Tommasina
    Liberati, Anna Marina
    Derudas, Daniele
    Oliva, Stefania
    Morabito, Fortunato
    Carella, Angelo Michele
    Gentili, Silvia
    Saraci, Elona
    Petrucci, Maria Teresa
    Sonneveld, Pieter
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
12345